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A key feature of myogenesis is the fusion of
myoblasts to form multinucleate myotubes. Recent
work in Drosophila has uncovered a collection of
genes that operate at different stages of this
process. Some interactions between them have
been described that begin to define links from
outside the cell via the plasma membrane to the
cytoskeleton. Future studies will establish the extent
to which the molecular mechanisms of myoblast
fusion are conserved between Drosophila and other
animals, as found in other aspects of myogenesis.
Introduction
One fascinating feature in the formation of muscle is
the fusion of myoblasts to make multinucleate syncy-
tia. The interest in this phenomenon is sparked both
by a desire to understand this characteristic and
unusual aspect of muscle cell biology and by a hope
that fusion may be a route for new therapies for a
range of diseases [1]. Studies in Drosophila
melanogaster have proved fruitful in the analysis of
many aspects of the molecular genetics and cell
biology of muscle development, and over the last few
years there has been considerable progress in the
analysis of myoblast fusion (reviewed in [2–4]). Work
published in a recent clutch of papers has advanced
the field still further, both conceptually and in the iden-
tification of the molecular players [5–15]. This review
concentrates on the findings of these recent studies.
The Story So Far
The formation of the Drosophila mesoderm and its
subsequent subdivision into groups of cells that will
differentiate in a particular way has been extensively
analysed [16–21] and reviewed [22–24]. One group of
these cells is the somatic mesoderm that differenti-
ates to form the somatic muscles of the body wall.
There is a stereotypic pattern of thirty such muscles of
different sizes and shapes in each hemisegment of the
embryo. These muscles are the principle focus of this
review and have many similarities to vertebrate skele-
tal muscle. They form in the following way. Within the
somatic mesoderm, muscle progenitors are singled
out from their neighbours by lateral inhibition in a
similar Notch-regulated process to that used in neu-
rogenesis (Figure 1A). Progenitors then divide to form
‘founder cells’ (Figure 1B). Founders endow the devel-
oping muscles with their specific characteristics
through the expression of so-called ‘muscle identity’
genes (reviewed in [23–25]). An individual founder then
attracts and fuses with the other cell type derived from
the somatic mesoderm, the Fusion Competent
Myoblasts (FCMs), and recruits them to its pattern of
muscle identity gene expression (Figure 2). Initially,
muscle precursors with two or three nuclei are
formed, which enlarge by further fusion to form the
mature individual multinucleate myotubes (Figure 2).
Fusion is asymmetric: founders fuse with FCMs, but
neither myoblast type fuses with itself [26,27].
A framework for understanding aspects of somatic
muscle fusion is provided by the studies of Bate and
of Doberstein et al. [28,29]. The former analysis
revealed when and where myoblast fusion occurs,
described the formation of muscle precursors with
extensive fine processes, and provided evidence for
founder cells. The latter revealed many distinct steps
in the fusion process, including ultrastructural detail at
the membrane through electron microscopic analysis,
and established that different genes act at different
stages in myoblast fusion. Examples of genes whose
mutant phenotypes are disruption of myoblast fusion
at different stages include myoblast city (mbc), Dmef2,
blown fuse (blow) and Dtitin [29–33]. Each protein
product is found in both classes of myoblasts, the
founders and the FCMs.
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Figure 1. The development of founders and fusion competent
myoblasts (FCMs).
(A) Formation of two muscle progenitors (brown) through lateral
inhibition from two clusters of somatic mesoderm cells in one
hemisegment of the developing embryo. (B) Muscle progenitors
(brown) divide to form two founder cells (shades of red). FCMs
are shown in blue. (C,D) Distribution of proteins in founder cell
(red) and FCM (blue). There are three sets of molecules:
surface, cytoplasmic and nuclear. Some are asymmetrically
distributed: Duf, Ants, Rols and ‘identity genes’ in founders
(shades of red); and Sns, Hbs and Minc/Lmd in FCMs (shades
of blue). Other proteins are in both cell types and include Rst,
Mbc, Blow, Titin, Mef2 (shades of purple). Additional proteins
implicated in fusion, but not shown, include the Rho-like
GTPase Drac1 [41] and the SH2/3 adaptor protein, D-Crk [42].
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Considerable interest was sparked by the discovery
of two other genes, dumbfounded (duf) and sticks and
stones (sns) [34,35]. Both genes encode immunoglob-
ulin superfamily members with the structure of a
transmembrane adhesion or signalling molecule. They
too affect myoblast fusion, but unlike the molecules
known previously, are specifically expressed: duf only
in founders, and sns only in FCMs. This was striking
because of the known asymmetry of the fusion
process. A working model emerged in which FCMs,
characterised by sns expression, move towards
founders in response to Duf, which had been shown
to function as a myoblast attractant. Fusion then pro-
ceeds with symmetrically distributed cytoplasmic or
membrane-associated proteins like Mbc, Blow and D-
Titin functioning on both sides of the membrane.
The model had few details. It also raised many
questions: are there other founder-specific or FCM-
specific molecules? How do the players interact and
co-operate in fusion? Are cell surface molecules other
than Duf and Sns involved? Does Duf function at
levels other than as an attractant? And do duf and sns
function in systems other than Drosophila somatic
muscle fusion? Some answers to these questions are
provided by the recently reported analyses reviewed
here that include the descriptions of novel genes iden-
tified in a variety of screens [5–15].
New Cytoplasmic Proteins
The answers begin with two genes isolated in inde-
pendent screens for genes that affect muscle devel-
opment. They are antisocial (ants) and rolling pebbles
(rols) [5–7]. Mutation in either gene blocks myoblast
fusion and results in no multinucleate myotubes. In
contrast to duf and sns, both ants and rols encode
proteins that are cytoplasmic and appear to become
enriched at the plasma membrane during fusion. Each
has multiple protein–protein interaction domains and
these are organised in a remarkably similar way: at the
amino terminus is a RING finger, and at the carboxyl
terminus there are nine ankyrin repeats followed by
three tetratricopeptide repeats (TPRs) and coiled coil.
Chen and Olson [5] then investigated the proteins with
which Ants might interact. They undertook a series of
immunoprecipitation assays in S2 cultured cells co-
transfected with tagged Ants together with tagged
Blow, Sns, Duf or Mbc. No interaction of Ants with
Blow or Sns was detected. However, Ants did interact
with both Duf, the transmembrane protein, and Mbc,
a cytoplasmic protein implicated in mediating
changes in the cytoskeleton [36]. This is the first direct
evidence that specific proteins identified for their role
in myoblast fusion physically interact.
The significance of this work is that Ants may be
part of a protein complex that links the membrane to
the cytoplasm and which may integrate the initial
myoblast attraction event with cytoskeletal reorgani-
sation in the developing myotube. Given its structural
similarities to Ants, Rols too may be involved in the
same or a similar complex. There is no direct evi-
dence, but some findings are consistent with the idea
(see below). However, one tantalising glimpse of some
other function for rols is the presence of a lipolytic
enzyme motif [6]. Although its role in Rols has not
been explored directly, an indication that it may be
significant comes from the analysis of two Rols iso-
forms, 6 and 7, produced through alternative splicing
[6,7]. Rols7 can rescue the rols mutant phenotype and
contains the lipolytic motif, whereas Rols6 does not
contain this motif and cannot rescue the mutant [6].
The expression patterns of ants and rols are strik-
ing. In common with duf, both ants and rols7 are
expressed in founders and not FCMs, and their tem-
poral expression broadly coincides with the fusion
process [6,7]. There are two points of interest here.
First, it had been suggested that there might be
founder cell-specific genes in addition to duf because
of the observation that expressing Duf in the FCMs
did not make these cells fuse with each other [34]. So,
this finding was anticipated, although it has been
found that co-expression of Rols with Duf is also not
sufficient for ectopic myoblast fusion [6]. Second, the
discovery of founder-specific cytoplasmic proteins
indicates that the asymmetry of the fusion process
extends to the molecular machinery inside the founder
cell and does not simply reside with surface mole-
cules (Figure 1C,D).
In their analysis of rols, Rau et al. [7] highlighted
another aspect of myoblast fusion that hitherto has
not received much attention. Muscle precursors are
formed by the initial fusion of the founder with one or
two FCMs. Precursors then grow by fusion. The ques-
tion is whether or not there are distinct genes required
for these sequential steps. From a careful analysis of
the rols mutant phenotype it is apparent that rols is
not required for the initial fusion, but is required in the
muscle precursor for the subsequent recruitment of
further FCMs to form the multinucleate myotube [6,7].
A requirement at this stage contrasts with other
mutants, such as mbc, in which the block is earlier
and almost no fusions occur (Figure 2) [30,37]. At
present it isn’t known how earlier fusion events may
differ from later ones.
Fusion Competent Myoblasts — Independent and
Non-Uniform
Understanding fusion requires an in depth knowledge
of both partners in the process. One of them, the
FCMs, have been relatively unexplored and generally
have been thought of simply as a uniform population
of myoblasts that were not selected to be founders.
However, two recent papers ensure that they will now
attract more attention [8,9]. Analysis of a gene called
myoblasts incompetent (minc) or lame duck (lmd)
shows that the FCMs have their own differentiation
program and also appear not to be a uniform popula-
tion. minc/lmd was identified in two screens, one for
genes affecting myogenesis, the other for proteins
that bind a mef2 enhancer. Incidentally, the same
gene has also been identified in two expression based
screens [38,39].
In minc/lmd mutants the founders differentiate nor-
mally, but there is a failure in FCM differentiation and
there is no myoblast fusion at all [8,9]. Unexpectedly,
this indicates that the FCMs have their own differenti-
ation program separate from that in founders.
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minc/lmd encodes a putative zinc finger transcription
factor related to vertebrate Gli proteins and ascidian
Macho1 [8,9], and may therefore control expression of
a group of genes required for FCM differentiation. It is
apparent that minc/lmd has roles in steps common to
all myogenic cells, such as mef2 expression, as well
as in steps specific to FCMs, for example sns expres-
sion [8,9].
In the somatic mesoderm minc/lmd is expressed in
immature myoblasts, predominantly in the FCMs.
However, and unexpectedly, the FCMs are found to
be non-uniform with respect to the nuclear localisation
of Minc/Lmd [8]. Nuclear localisation correlates with
expression of mef2 and it is suggested that nuclear
Minc/Lmd is required for the expression of mef2. This
non-uniformity is consistent with an earlier suggestion
that the differentiation state of cells competent for
fusion may be time-dependent [2]. An additional facet
to this may be the temporal and spatial expression in
FCMs of another gene, hbs (see below), which led to
the suggestion that there may be undescribed func-
tional differences within the FCM population [12].
Taken together these observations indicate that the
FCMs are not a uniform population and, more specu-
latively, that all fusions may not be equal: earlier could
be distinct from later.
Another aspect to a lack of uniformity within the
FCMs is the idea, which has been considered for
some time, that the cells that fuse together to make
one muscle are distinguishable from those that fuse to
make a distinct, nearby muscle. This is certainly one
way in which muscle development could be organ-
ised. In fact there is no evidence for a patterning
mechanism that selects myoblasts in groups assign-
ing them to make a specific muscle. Rather, pattern-
ing mechanisms govern the founders and these then
recruit FCMs [34]. Notwithstanding this, one could
imagine that the myoblasts that fuse to make an indi-
vidual muscle are clonally related, as they develop in
close proximity. A recent elegant study has shown
that they do not have to be. Klapper et al. [10] have
developed a technique that allows them to detect 
syncytia. The technique in which they produce genetic
mosaics of cells is general and does not apply just to
muscle. They transplant single cells carrying a
UAS–reporter gene construct into a recipient embryo
that carries a constitutively active GAL4 gene. The
GAL4 transcription factor will activate the reporter
gene through binding to the UAS motif only when cells
of the two genotypes fuse. When they apply the tech-
nique to muscle development, they find activation of
the reporter in most somatic muscles, although not all,
and in this way show that non-clonally related
myoblasts can fuse with each other. They conclude
that clonal relationships generally seem to play no
crucial role in the selection of the participating cells.
Taken together the available evidence indicates that
fusion between founders and FCMs, and later between
precursors and FCMs, simply occurs with the nearest
FCMs. Given such a mechanism, an immediate ques-
tion to ask is how do each of the 30 different muscles
in each hemisegment end up different specific sizes.
The smallest contain just 3–4 nuclei, the largest 20–25
[28]. Current ideas suggest that size is one character-
istic of an individual muscle governed by the muscle
identity genes. A component of a possible mechanism
would therefore involve the regulation by muscle iden-
tity genes of one, or probably more, of the molecules
critical to fusion. The transient expression, correlating
with fusion, of duf, rols and ants is consistent with reg-
ulation of these genes being one level of control.
New Proteins at the Cell Surface
Another area of unanswered questions in myoblast
fusion was at the membrane and centred on the
immunoglobulin superfamily members Duf and Sns.
The description and analysis of two other members of
this family has necessitated a reappraisal of how Duf
— also called Kirre — and Sns might function. The
first gene is roughest (rst), which maps very close on
the chromosome to duf and encodes a protein with a
similar extracellular domain to Duf [11]. A chromoso-
mal deletion that removes both genes causes a severe
phenotype with no myoblast fusion [11,34]. Either rst
or duf can rescue this mutant phenotype and each
can act as a myoblast attractant [11,34]. However,
lack of either gene alone has little effect on muscle
development [11].
Despite the apparent functional redundancy shown
by this work there are two notable differences
between rst and duf. The first is that although they are
clearly structurally related, the intracellular domains
are very different in length and share only 15% amino
acid identity [11]. This might affect proteins that inter-
act with the cytoplasmic domains of Rst and Duf. The
second is the pattern of expression. Notably, and in
contrast to duf, rst is expressed in both founders and
FCMs. Furthermore, duf expression is generally much
more restricted than rst and is switched on later in
development. Nevertheless, Strunkelnberg et al. [11]
reasonably conclude, given the overlapping mesoder-
mal expression patterns of rst and duf and the signif-
icant structural similarity between the two proteins,
that rst and duf have at least partially redundant func-
tions during muscle development.
Figure 2. Stages of myoblast fusion.
Myoblast fusion is a multistep process. First, FCMs (blue) are
attracted towards founder cells (red). In duf, rst double mutants
the FCMs are not attracted and their filopodia extend in random
orientations rather than towards the founders [34]. Second,
FCMs associate with the founders. They then fuse to form bi-
or tri-nucleate muscle precursors and are recruited to the
founder’s pattern of gene expression. This step is blocked in
mbc mutants [30,37]. Lastly, in a process that requires rols,
additional FCMs fuse with the muscle precursors to form mult-
inucleate myotubes [6,7]. For clarity only a few gene functions
and some of the steps are shown.
  Current Biology  
Founder
FCM FCM
duf+rst-/- mbc-/- rols-/-
The second new family member is hibris (hbs), which
has an extracellular domain closely related to Sns and
human Nephrin [12,13]. Although hbs is expressed
more widespreadly than sns, it too is expressed in
FCMs but not in founders, and so is another example
of molecular asymmetry in fusion (Figure 1C-D). Hbs is
localised at the cell membrane and has similar tempo-
ral and spatial expression to Sns, although there are
differences. However, in contrast to sns, hbs mutations
do not have a dramatic effect on muscle, although the
precise phenotype is debated [12,13]. Nevertheless,
over-expression of Hbs in the somatic mesoderm dis-
rupts myoblast fusion. Moreover, phenotypic analysis
of hbs and genetic interactions with sns suggest Hbs
is a dose-dependent regulator of fusion and may
antagonise Sns function [12].
Four immunoglobulin superfamily members have
therefore been identified to date. Although hbs and rst
are expressed more widespreadly than their structural
counterparts sns and duf, all four molecules must be
considered in constructing a model for myoblast
fusion. How do they function? Because other
members of the immunoglobulin superfamily have
roles in adhesion and signalling these are properties
to consider closely for these four cell surface
Drosophila proteins. The first question to ask is
whether these proteins physically interact, homotypi-
cally or heterotypically. The first indication of such an
interaction has recently been reported by Dworak et
al. [13]. They find that cells transfected with duf aggre-
gate with cells transfected with sns. This is consistent
with a physical interaction between Duf and Sns that
could link founder with FCM by adhesion. They
present similar evidence for Duf and Hbs, but detect
no interactions with rst-transfected cells. More
detailed studies will no doubt follow both to investi-
gate these interactions further and explore possible
ligand–receptor relationships.
As described above Duf and Rst can act in the very
first step of fusion as myoblast attractants (Figure 2),
and this is a function that could be mediated through
adhesion [4,34]. However, because no fusion at all is
seen in embryos mutant for duf plus rst [34], where
some FCMs will be in the vicinity of founders, it seems
that these two surface proteins may also function later
in the fusion process, possibly through signalling. This
idea is supported by experiments demonstrating links
between Duf and the cytoplasmic proteins Ants and
Rols, which then link with reorganisation of the
cytoskeleton. During fusion in normal development
Ants redistributes from the cytoplasm to localised
sites at the membrane. This does not occur in duf, rst
double mutants, and the binding of Duf by Ants
described earlier suggests that direct protein–protein
interactions lie behind this [5].
Such interactions may also provide a link to
cytoskeletal changes through Mbc, because Ants
binds Mbc [5] and mbc mediates cytoskeletal changes
[36]. Rols may also function in the same complexes 
or in others operating in parallel. The normal redistrib-
ution of Rols to the membrane does not occur in duf,
rst double mutants, and co-overexpression of Duf 
with Rols results in Rols becoming enriched at the
membrane [6]. D-Titin, a scaffold-like protein, is also
recruited to fusion sites through membrane-associated
Rols [6]. Together these findings suggest that there is
a cascade of events operating from the surface pro-
teins in founders that leads to the formation of spe-
cialised sites along the membrane required for fusion
that in turn link to cytoskeletal organisation.
Duf and Sns Outside Somatic Muscle
When duf and sns were first described a pressing
question was whether they functioned in cell fusions
apart from in Drosophila somatic muscle. Recent work
shows that they do [14,15]. The system investigated
was Drosophila midgut visceral muscle, which is a lat-
ticework of longitudinal and circular fibres that
encloses the midgut endodermal tube. The initial
studies on duf and sns reported expression of these
two genes in the visceral mesoderm [34,35]. This
expression of two fusion genes was perplexing in that
previous work and beliefs had it that Drosophila vis-
ceral muscle was not syncytial. However, it has now
been found, using both dye-filling of cells and the
elegant technique of Klapper et al. described above,
that both the longitudinal and circular fibres are actu-
ally small syncytia [10,14,15]. These groups then
addressed the role of duf and sns in the development
of the midgut visceral muscle [14,15]. It, like the
somatic muscle, was found to be organised with
founders that express duf and fusion competent cells
that express sns. Importantly, in mutations either of duf
plus rst, or of sns, the two populations remain distinct
and do not closely adhere and fuse as they would in
the wild type.
Concluding Remarks
In the last year many more players in the multistep
process of myoblast fusion have been identified.
Progress in defining what these proteins do, and when
do they do it, will require a detailed analysis of the cell
biology, including at an ultrastructural level, of each
mutant. Further studies will also establish the extent
to which both the molecules and the developmental
strategy of myoblast fusion in Drosophila are con-
served in other species. Certainly the finding and
initial analysis of mammalian ants and mbc suggests
that elements will be conserved [5,36,40].
Another area of particular interest will be defining
any spatial and temporal heterogeneity in the com-
plexes containing immunoglobulin superfamily
members. This will impact on two areas of myoblast
fusion: the asymmetry of the process and the emerg-
ing idea that not all fusions are equal. There are cer-
tainly spatial differences (Figure 1C-D). There may be
surface complexes containing Duf and Rst on founders
and Sns, Hbs and Rst on the FCMs, and untangling the
relative contributions of Duf and Rst will be one chal-
lenge. However, the asymmetry of fusion is still not
understood. Although Duf expression is founder-spe-
cific, fusion can still occur without asymmetric expres-
sion of Duf, or Rst [11,34]. The answer may lie in the
asymmetric assembly of functionally distinct com-
plexes in which other asymmetrically distributed pro-
teins have a role.
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Establishing whether there is also temporal hetero-
geneity in the cell surface complexes is important.
This could be manifested in the founders or the FCMs,
which certainly appear to be heterogeneous in
aspects of their differentiation, and might indicate that
some myoblast fusions are indeed different from
others. All this lies in the future. For now it is apparent
that the current phase of gene identification and initial
analysis will continue for some time yet and then the
challenge will be to integrate this knowledge to
produce an all embracing molecular and cellular
picture of myoblast fusion.
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